Pregnancy Hypertension-An International Journal of Womens Cardiovascul

Article	Citations
PO1_20. Midtrimester drop in bp is not associated with a decreased risk for hypertensive disorder of pregnancy in a nulliparous cohort	571
PO6_15. Predictive utility for preeclampsia of the SFLT-1/PLGF ratio test in routine clinical practice: a retrospective analysis of 1,397 pregnancies with suspected pre-eclampsia	135
PO6_19. The diagnostic accuracy of American college of cardiology/American heart association blood pressure categories for identification of women and babies at risk of adverse pregnancy outcomes – a	43
PO8_1. CANCELLED : Predictive value of longitudinal maternal serum angiogenic marker assessment for maternal adverse outcomes in pregnancies with preeclampsia	31
OP14_5. Metformin to prolong pregnancy in preterm preeclampsia	27
OP15_4. A biopolymer-fused form of placental growth factor for treatment of preeclampsia	22
O-001. Acute cardiovascular and hemodynamic consequences of placental growth factor administration in guinea pigs	21
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to lett	20
P-002. Evidence of neuroinflammation and injured blood–brain-barrier in eclampsia	19
PS-1. Future interaction among International Society of Hypertension (ISH), Japan Society of Hypertension (JSH) and ISSHP	19
Exploring proteomics in the search of novel predictive cardiovascular biomarkers for preeclampsia	18
Comparison of subfoveal choroidal thickness in patients with hypertensive disorder of pregnancy versus normotensive pregnant women in third trimester of pregnancy	17
GSTP1-A313G genetic polymorphism and the risk of preeclampsia in pregnant women: A study in the northern population of Iran	17
Six-week blood pressure trends in postpartum patients utilizing remote patient monitoring program	16
Examining changes in clinical management and postpartum readmissions for hypertensive disorders of pregnancy over time	16
Comprehensive transcriptome mining identified the gene expression signature and differentially regulated pathways of the late-onset preeclampsia	15
How digital health affects the patient-physician relationship: An empirical-ethics study into the perspectives and experiences in obstetric care	15
New 3D cardiac in vitro models for assessing the maternal cardiovascular health five years post hypertensive disorders of pregnancy	15
Alterations in the metabolic status of amino acids in newborns of pre-eclampsia women	14
Sociodemographic risk factors associated with patient follow-up after implementation of a CardioObstetrics program	14
Comparison of Zuspan regimen and its 12-hour modification in women with severe pre-eclampsia and eclampsia in two hospitals in Abeokuta	14
Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia – A qualitative study	13
PO2_08. decreased sodium (NA + ) buffer capacity in pregnancy and in women following pre-eclampsia	13
P-097. Exploring education preferences of Australian women and healthcare providers regarding long-term health after hypertensive disorders of pregnancy – A qualitative rerspective	13
Perceptions and experiences of blood pressure self-monitoring during hypertensive pregnancy: A qualitative analysis of women’s and clinicians’ experiences in the OPTIMUM-BP trial	13

PO7_3. Patient perception of home blood pressure monitoring kits	13
Response to letter to the editor	13
Reduced urinary angiotensinogen excretion in preeclampsia	13
Extended postpartum outcomes with systematic treatment of and management of postpartum hypertension program	13
P-059. Prevalence and risk analysis of early-onset and late-onset of hypertensive disorders of pregnancy	13
Management of hypertension in the early postpartum: A randomized controlled trial	12
Association of MTHFR C677T and A1298C variants with preeclampsia risk and angiogenic imbalance in Tunisian women	12
The sFLT-1/PlGF ratio versus biochemical parameters in prediction of adverse outcomes in preeclamptic women	12
Impact of maternal hypertensive disorders of pregnancy on brain volumes at term-equivalent age in preterm infants: A voxel-based morphometry study	12
Conformation-dependent anti-Aβ monoclonal antibody signatures of disease status and severity in urine of women with preeclampsia	11
Diagnostic accuracy of urine dipstick tests for proteinuria in pregnant women suspected of preeclampsia: A systematic review and meta-analysis	11
Short communication: Is there any benefit of initiating aspirin before the 11th week of gestation?	11
Letter to the editor: Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	10
P-023. Uterine vascular resistance and other maternal factors associated with the risk of developing hypertension during pregnancy	10
WITHDRAWN: COVID-19 not hypertension or diabetes increases the risk of preeclampsia among a high-risk population	10
Perinatal outcomes and their determinants among women with eclampsia and severe preeclampsia in selected tertiary hospitals, Eastern Ethiopia	10
P-026. Association between vascular remodeling biomarkers and the placentary bed in pre-eclampsy	10
Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study	10
Re: Vascular endothelial growth factor C/A 2578 gene polymorphism and umbilical artery doppler in preeclamptic women. Mowad HH, Abougabal KM, Fahim AS, Shehata NAA, Ali HAA, Nasser MZ. Pregnancy Hyper	10
GS-4. Epidemiology of preeclampsia	9
P-017. The Elecsys sFlt-1/PlGF ratio for short-term prediction of preeclampsia in the Japanese cohort of the PROGNOSIS Asia study: Economic evaluation	9
OP14_4. Epigenetic regulation by STOX1 in trophoblast cells lines	9
SY2-3. The role of autophagy in pathophysiology of PE	9
P-104. Clinical characteristics and sequelae of intrapartum hypertension	9
PO4_2. Genome-wide association study sheds more light on the pathophysiology of preeclampsia	9
P-050. Potency of Tokishakuyakusan in treating preeclampsia: Drug repositioning method by in vitro screening of the Kampo library	9
SY5-1. Timing of delivery in late preterm pre-eclampsia	9
O-005. Circulating biomarkers for neurological complications in preeclampsia	9
PO9_05. Endothelial glycocalyx dysfunction in early- and late-onset preeclampsia	9
SY3-1. Long-term consequences of pregnancy complications: lessons from mouse models	9
Case of chorioamnionitis in ANA positive in second trimester of pregnancy	8
Home blood pressure monitoring and mobile health application practices among pregnant persons with and at risk of hypertensive disorders of pregnancy	8
Neuroimaging in eclampsia: A window into the correlates between neural pathology and maternal outcomes	8
Association between serum NfL and NfH with Antepartum and Postpartum Hypertension	8
Proteinuria in severe preeclampsia: Clinical significance in modern obstetrics	8
Smaller decrease in late second trimester blood pressure is associated with gestational hypertensive disease development	8
Rubidium – Initial observations of an enigmatic element in pre-eclampsia	8
Validation of urinary Congo Red preeclampsia detection point-of-care devise	8
Effect of positioning on blood pressure measurement in pregnancy	8
Provider adherence to aspirin prophylaxis prescription guidelines for preeclampsia	7
History of IgA vasculitis with nephropathy (Henoch-Schonlein purpura nephritis) can be a strong risk factor for preeclampsia	7
Y-004. Investigating nitrate metabolism and the oral microbiome in hypertensive pregnancies	7
P-103. Incidence and clinical characteristics of hypotension in pregnancy	7
P-009. Associations between circulating sFlt-1 and PlGF and preeclampsia with severe maternal complications, or eclampsia	7
Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia	7
Secondary hyperaldosteronism due to renal agenesis: Rare cause of secondary hypertension in pregnancy	7
P-034. Decreased circulating levels of plasmacytoid dendritic cells in women with early-onset preeclampsia	7
PO2_07. Metabolic outcomes in women six months and two years after hypertensive versus normotensive pregnancy – a P4 study	7
PO7_1. Patient perceptions regarding remote patient monitoring for postpartum hypertension	7
Congo red dot test in the early prediction and diagnosis of pre-eclampsia in a tertiary health care centre in India	7

Maternal bradycardia heralding deteriorating HELLP syndrome (pregnancy hypertension)	7
SY4-4. Role of sFlt-1 on the development of preeclampsia: basic and clinical approach	7
PO2_14. Impact of previous hypertensive disorders during pregnancy on long-term cardiovascular consequences in women with severe hypertension	7
PLGF – A pioneer in prediction of pre - eclampsia	6
OP08_2. New generation antiplatelet therapies decrease soluble FMS-like tyrosine kinase-1, enhance antioxidant cytoprotection, rescue vascular and endothelial dysfunction and decrease hypertension in	6
Corrigendum to “Down-regulation of B2R contributes to preeclampsia by inhibiting human trophoblast cell invasion and angiogenesis” [Pregnancy Hypertens. 21 (2020) 14–22]	6
PO1_04. Innovative use of Robson classification to understand prevalence of preeclampsia: findings from a Brazilian survey	6
PO6_06. Soluble endoglin versus SFLT-1/PLGF ratio: detection of preeclampsia, hellp syndrome and FGR in a high-risk cohort	6
Comparison of double-filtration plasmapheresis (DFPP) versus heparin-mediated extracorporeal LDL-precipitation (HELP)-apheresis in early-onset preeclampsia	6
PO6_21. The utility of the SFLT-1/PLGF ratio among patients with or without hypertension who are suspected of having preeclampsia	6
Novel electronic health records applied for prediction of pre-eclampsia: Machine-learning algorithms	6
PO8_4. Late postpartum eclampsia with multifocal posterior reversible encephalopathy syndrome after twin gestation: a case report	6
Exposure to higher concentrations of exogenous ELABELA causes HTR-8/SVneo trophoblast cell dysfunction: A possible pathogenesis of pre-eclampsia	6
PO9_13. Towards ‘the best method to determine proteinuria’ in pregnant women	6
PO7_4. Short animated videos aimed at the greatest number of women, to allow and promote self-care in preeclampsia	6
PO3_11. Elective anticipation of delivery in preeclampsia with cervical preparation by prostaglandins: success for vaginal delivery	6
Validation of the Finnish Care register for Health Care diagnoses for preeclampsia, gestational diabetes and preterm delivery	6
Nifedipine outperforms labetalol: A comparative analysis of hypertension management in black pregnancies	6
Angiogenic factors and prediction for ischemic placental disease in future pregnancies	6
OP04_5. Risk for cardiovascular and cerebrovascular diseases in women during first ten years after pre-eclampsia pregnancy in the FINNPEC study	6
Perfluorooctane sulfonic acid increases blood pressure and disrupts vascular function and placental steroidogenesis in pregnant rats	6
PO3_09. Inhibition of arginase and supplementation with folic acid decrease ROS production in endothelial cells incubated with plasma from preeclampsia pregnant	6
Determining the relationship between severity of proteinuria and adverse maternal and neonatal outcomes in patients with preeclampsia	6
The unintended consequences of modernity: Pollution and its effect on reproductive, maternal and fetal health	6
PO6_20. The SFLT-1/PLGF ratio for the prediction of preeclampsia-related adverse fetal and maternal outcomes in women with preexisting diabetes	5
Women’s perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia	5
SY1-2. COMT in the biology of preeclampsia	5
P-106. COVID-19 and pre-eclampsia: a literature review	5
Reference-range of arterial stiffness by cardio-ankle vascular index in normal pregnancy	5
Differential effects of renin-angiotensine-aldosteron system inhibition, sympathoinhibition and low sodium diet on blood pressure in women with a history of preeclampsia: A double-blind, placebo-contr	5
Editorial Board	5
Assessing the Mediterranean diet adherence during pregnancy: Practical considerations based on the associations with cardiometabolic risk	5
SY5-3. Maternal mortality: how can lives are saved?	5
Low physical activity levels 1 year after pregnancy complications	5
Preeclampsia and eclampsia: Its burden and distribution across facilities in Ethiopia	5
Signs or symptoms of suspected preeclampsia – A retrospective national database study of prevalence, costs, and outcomes	5
PO1_03. Individual, social, and environmental risk factors for hypertensive disorders of pregnancy in Ghana: A systematic review	5
Persistence of abnormal uterine artery flow postpartum: Case-control study	5
P-031. Vitamin D maintains viability and decreases apoptosis in huvec and modulates inflammation in placenta from preeclamptic women cultured with TNF-α	5
P-056. Profound changes in hemodynamics proving late-onset PE being of maternal origin	5
Increased adherence to ACOG diagnostic guidelines for HDP following a workshop in Bolivia, a LMIC	5
Barriers and facilitators for adequate calcium intake during pregnancy: A mixed methods study	5
Welcome Message by Congress Chair of ISSHP 2021	5
PO2_06. Lymphatic mimicry of endothelial cells in utero-placental spiral arteries is impaired by overexpression of HSFLT1 in a murine model for preeclampsia	4
P-035. Behavioral risk factors of cardiovascular diseases in pregnant women. Prevalence and socioeconomic predictors in Burkina Faso: a cross-sectional study	4
PO1_16. Changes in early pregnancy blood pressure among nulliparas that developed a hypertensive disorder of pregnancy	4
OP05_4. Umbilical cord plasma from women with pre-eclampsia reduces brain endothelial cell migration involving alterations in the VEGFR2-COFILIN-F-ACTIN polymerization pathway	4
Maternal pulmonary hypertension and cardiopulmonary outcomes during delivery hospitalization in the United States: A nationwide study from 2016–2020	4
PO8_3. Investigating the role of biomarkers (SFLT-1/PLGF) in cases of covid-19 and its use to distinguish preeclampsia and guide clinical management	4
Impact of antenatal SARS-CoV-2 infection on development of hypertensive disorders of pregnancy in a large, diverse, cohort	4
P-088. Aspirin and the risk of birthing a small for gestational age infant; A Swedish population-based study	4
PO3_10. CANCELLED : A randomized controlled trial comparing low doses of aspirin in the prevention of preeclampsia (ASAPP): the first 100 patients	4
OP05_5. Characterization of prokineticins receptors anatagonization in preeclampsia: in vitro and in vivo studies	4
Diagnostic challenges of Thrombotic Microangiopathy (TMA) in a pregnant woman remote from term and a case report of atypical TTP	4
OP15_5. Metformin to treat preeclampsia: mechanism of action influences mitochondrial dynamics	4
Uterine artery Doppler for the prediction of outcome in pregnancies complicated by hypertensive disorders of pregnancy	4
SY6-2. Possible role of statin to prevent preeclampsia	4
Residual liver stiffness in the postpartum period in women with preeclampsia and healthy women: A case-control study	4
Eplerenone: A candidate drug to mitigate long-term maternal vascular dysfunction following preeclampsia	4
PO1_10. Incidence of prematurity in pregnancies complicated by hypertensive syndromes: A systematic review	3
P-072. Severe anemia and preeclampsia – Case report and literature review	3
P085. Should we consider Hypertensive Disorders of Pregnancy a risk factor for postpartum haemorrhage?	3
Improving treatment of severe hypertension in pregnancy and postpartum using a hypertensive pathway	3
Hypertension and diabetes risk in patients with previous pregnancy-related disorders and the time to onset of the disease	3
SY2-1. Enhanced adenosine signaling in the placenta: a crucial pathogenic factor and a possible therapeutic target for preeclampsia	3
Relevance of maternal sodium level for preeclampsia-associated adverse pregnancy outcomes	3
Preeclampsia in women with lupus – Influence of aspirin and hydroxychloroquine on pregnancy outcome	3
Uterine artery doppler as prognostic indicator in Fetal growth restriction in third trimester	3
Association of pre-pregnancy subclinical insulin resistance with cardiac dysfunction in healthy nulliparous women	3
Detection of hypertension and blood pressure phenotypes using ambulatory blood pressure monitoring in women with past hypertensive disorders of pregnancies	3
Analyses of selected tumour-associated factors expression in normotensive and preeclamptic placenta	3
OP06_5. Alcohol exposure prior to pregnancy - does risk consumption increase the risk of preeclampsia and low birth weight? a swedish population-based cohort study	3
P-100. Retinal microvascular oxygen saturation in women 3 years after hypertensive disorders of pregnancy	3
Retrospective study for classifying hypertensive disorders of pregnancy by time of onset	3
New cardiac platform for the management of cardiovascular risk following preeclampsia using in vitro bioengineered cardiac spheroids and patient-derived stem cells	3
Cardiovascular morbidity and mortality following hypertensive disorders of pregnancy	3
Bioprinting a placental model to study the effects of current and emerging treatments of preeclampsia	3
Y-017. SAFE@HOME: Digital health platform facilitating a new care path for women at increased risk of preeclampsia – A case-control study	3
Diagnosis of placental insufficiency independently of clinical presentations using sFlt-1/PLGF ratio, including SGA patients	3
SC3_3. FKBPL signalling in placental development and preeclampsia	3

Hypertensive disorders of pregnancy in women with autoimmunity: A rising incidence?	3
A study of long-term prognosis after delivery in patients with hypertensive disorders of pregnancy	3
A multi-ancestry genome-wide association study identifies novel candidate loci near the RARB gene associated with hypertensive disorders of pregnancy in the personalized environment and genes study	3
No association in maternal serum levels of TMAO and its precursors in pre-eclampsia and in non-complicated pregnancies	3
PO9_07. CANCELLED : Grading the severity of early-onset preeclampsia using parameters considered for indication for delivery: a Delphi consensus	3
Risk factors of preeclampsia among pregnant women admitted at labor ward of public hospitals, low income country of Ethiopia; case control study	3
O-010. Annual BMI gain is associated with the risk of HDP in the subsequent pregnancy	3
Is a sFlt-1/PlGF cutoff of 38 suitable to predict adverse outcomes in pregnancies with abnormal uterine artery Doppler velocimetry in the second trimester?	3
Blood pressure measurement and adverse pregnancy outcomes – Testing alternatives to 140/90 mmHg	3
SY10-2. Management of severe postpartum TMA	3
Self antenatal monitoring of blood pressure at home as interVention ( SAMBHAV) in hypertensive women: Challenges in the developing country	3
Y-016. Interaction between previous preeclampsia and inter-pregnancy chronic hypertension development on preeclampsia risk in the subsequent pregnancy	3
SY8-1. Maternal diet and gut microbiota: effects on gut blood pressure and metabolism	3
First trimester screening (FTS) for placental pathology – Comparison of the efficacy of different methods	3
Improving compliance with guidelines for hypertensive disorders of pregnancy through an electronic health record alert: A retrospective chart review	3
Impact of Maternal Early Warning Trigger (MEWT) tool on the incidence of eclampsia	3
PO1_19. Maternal Mortality from Hypertension in Pregnancy in Brazil from 2015 to 2019	3
Circulating Activin A is elevated at 36 weeks’ gestation preceding a diagnosis of preeclampsia	3
Cardiovascular mortality risk a decade after twin and singleton pregnancies complicated by hypertensive disorders of pregnancy	2
Letter to the editor: Caution: Not all sFlt-1/PlGF ratios are the same	2
P-054. Maternal hemodynamics assessed by USCOM® device in patients with hypertensive disorders of pregnancy during peripartum	2
P-057. Preeclampsia prediction based on urine peptidome study	2
Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction	2
Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women	2
Postpartum readmissions for hypertension in patients discharged on Labetalol and Nifedipine in a Tertiary Care Centre in South India	2
P-013. Negative predictive value of sFlt-1/PlGF ratio ≤ 38 for ruling out preeclampsia within 1–4 weeks of testing: A secondary analysis of the INSPIRE trial	2
PO1_11. Optimal timing of antenatal corticosteroid administration in pregnancies complicated by early-onset fetal growth restriction: The opticore study protocol	2
PO2_10. CANCELLED: Maternal vascular malperfusion lesions and preeclampsia are associated with microvascular dysfunction, worse cognition and circulating angiogenic biomarkers 8-10 after pregnancy	2
A tribute to Christopher Redman, MB, BChir, FRCP, FRCOG (ad eundum)	2
Self-monitoring blood pressure in Pregnancy: Evaluation of health professional experiences of the BUMP trials	2
Association of fetal sex with angiogenic factors in normotensive and hypertensive pregnancy states	2
OP09_1. Prepare: a stepped wedge cluster randomised trial to evaluate whether a risk stratification model can reduce preterm deliveries among women with suspected or confirmed preterm pre-eclampsia	2
Title Page	2
P-011. sFLT-1, PLGF e sFLT-1/PLGF levels in preeclampsia: correlation with mediated maternal results	2
Maternal C1q deficiency leads to impaired hemodynamic adaptations and cardiovascular dysfunction during pregnancy	2
The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice	2
Incidence of essential hypertension but not echocardiographic abnormalities at four years with a history of preeclampsia with severe features	2
Elevated expression of galectin-3, thioredoxin and thioredoxin interacting protein in preeclampsia	2
Y-019. Immunomodulatory effect of vitamin D on the activators of transcription and transcription factors of CD4+ T cell subsets in pregnant women with preeclampsia	2
OP07_4. Aspirin treatment improves reduced uterine perfusion pressure (RUPP)-induced cardiac dysfunction in pregnant rats	2
The significance of mitochondrial haplogroups in preeclampsia risk	2
OP07_6. Hydroxychloroquine effect on endothelium – a role in the treatment of preeclampsia?	2
Cardiovascular remodelling and reverse remodelling during pregnancy and postpartum: Looking at the right side	2
Clinical manifestations and complications of preeclampsia and eclampsia in populations residing at high altitudes and very high altitudes: A scoping review	2
OP06_4. Circulating concentrations of glyxocalyx degradation products in preeclampsia	2
Racial differences in healthcare utilization among patients with suspected or diagnosed preeclampsia: A retrospective cohort study	2
P-083. Aortic Dissection during pregnancy: A case report	2
Galectin-7 dysregulates renin-angiotensin-aldosterone and NADPH oxide synthase pathways in preeclampsia	2
SSRI use in pregnancy: Moving towards collaborative, evidence-based decision-making	2
sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19	2
Clinical study of fundoscopic findings in pregnancy induced hypertension	2
P-105. Probiotics supplementation increases the risk for preeclampsia	2
PO9_17. Interventions for improving subject enrollment in RCT	2
Preeclampsia prediction with blood pressure measurements: A global external validation of the ALSPAC models	2
Preeclampsia, gestational hypertension and incident dementia: A systematic review and meta-analysis of published evidence	2
Gestational weight gain among gravidae with hypertension receiving labetalol versus nifedipine	2
Is outpatient surveillance of preeclampsia without severe features still safe in contemporary obese Populations?	1
Sleep disordered breathing and the risk of severe maternal morbidity in women with preeclampsia: A population-based study	1
OP19_2. Luteolin, a natural flavonoid, attenuates the development of placental ischemia-induced hypertension in pregnant rats	1
Factors associated with persistence of hypertension in patients with hypertensive disorders of pregnancy	1
O-008. Influence of Hypertension in Pregnancy on Hematological Phenotypes of Preterm Infants with Gestational Age Inferior to 32 Weeks	1
Differential platelet activation and thrombo-inflammatory mechanisms in early onset and late onset preeclampsia	1
P-007. Are there differences in the decidualizing endometrial secretome in women with recurrent pre-eclampsia?	1
Prevalence and risk factors of labor-onset hypertension: A multicenter study in Japan	1
Association between maternal hypertensive disorders, fetal growth and childhood learning outcomes	1
P-075. A survey on the diagnosis and management of uteroplacental dysfunction in hypertensive disorders of pregnancy in Japan	1
SY10-4. Atypical Hemolytic Uremic Syndrome and Pregnancy	1
Editorial Board	1
O-006. Modulatory effect of two regimens of magnesium sulfate on the systemic inflammatory response in pregnant women with eclampsia or imminent eclampsia	1
SY4-1. Reliable urinary screening tests for preeclampsia	1
Reviewers	1
Pre-Eclampsia in pregnancy: A Knowledge, Attitude and Practice (KAP) Survey amongst specialists, junior residents and Primary Care Providers (PCPs) in India	1
Postpartum convulsion – An analysis	1
Y-007. Is the cut-off 38 the best value to predict adverse outcomes in pregnancies with abnormal uterine artery doppler In the second trimestre?	1
A Randomized control trial to compare the efficacy and Feto-maternal outcome of 75 Mg aspirin versus 150 Mg aspirin in women at high risk of pre-eclampsia	1
Differences in disease severity and delivery gestational age between black and white patients with hypertensive disorders of pregnancy	1
Intrapartum trends of NT-proBNP and hs-cTnT in patients with severe features of preeclampsia	1
Y-014. Two-year infant and maternal outcomes after planned delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial	1
P-040. Development of a machine-learning model to predict adverse outcomes in patients at risk for preeclampsia	1
PO6_13. Maternal biomarkers as a predictor for neonatal outcomes and timing of delivery	1
Patients and health care workers perceived challenges in managing preeclampsia, in Malawi	1
GS-2. It all comes down to timing of delivery	1
Eclampsia in Italy: A prospective population-based study (2017–2020)	1
OP05_3. Time-of-disease risk prediction of adverse maternal outcomes of pre-eclampsia using artificial intelligence	1
Postpartum clinic attendance, health services utilization and cardiometabolic screening in women with preeclampsia	1
OP04_6. The risk of new-onset neurological disorders after pregnancy-induced hypertension; a nation-wide register-based cohort study	1
PO1_07. Non proteinuric preeclampsia: Implications in the diagnosis and clinical and laboratory profile with 2013[StQuote]s new diagnostic criteria	1
P-033. Changes of natural cytotoxicity receptors of CD56dim and CD56bright NK cells in peripheral blood and decidua in preeclampsia	1
Placental and serum levels of human α-Klotho in preeclampsia & intra-uterine growth retardation: A potential sensitive biomarker?	1
Substantial decrease in preeclampsia prevalence and risk over two decades: A population-based study of 1,153,227 deliveries in Norway	1
Clinical presentation and predictors of eclampsia among women with hypertensive disorders of pregnancy in Ghana	1
Y-010. Prediction of hypertensive disorders of pregnancy based on home blood pressure monitoring	1
Tumor Necrosis Factor-alpha Blockade Improves Uterine Artery Resistance, Maternal Blood Pressure, and Fetal Growth in Placental Ischemic Rats	1
PO7_6. CANCELLED : Test of scale of a novel vital signs alert device to improve maternity care in Sierra Leone: a qualitative evaluation of delivery and implementation	1
Use of non-invasive cardiac monitoring to guide discontinuation of postpartum magnesium sulfate in individuals with preeclampsia with severe features	1